Fig. 3From: Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancerCNR1, RBM39, and ZNF207 mRNA levels in a. Breast cancer samples, analyzed by GEPIA and b Trastuzumab resistance breast cancer samples, analyzed by ONCOMINEBack to article page